成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

3'-Guanylic acid, guanylyl-(3'→5')-, cyclic nucleotide, diammonium salt (9CI)

3'-Guanylic acid, guanylyl-(3'→5')-, cyclic nucleotide, diammonium salt (9CI) Struktur
609343-82-0
CAS-Nr.
609343-82-0
Englisch Name:
3'-Guanylic acid, guanylyl-(3'→5')-, cyclic nucleotide, diammonium salt (9CI)
Synonyma:
Cyclic-di-GMP diammonium;cyclic diguanylate diammonium;5GP-5GP diammonium|||c-di-GMP diammonium;5GP-5GP diammonium|||c-di-GMP diammonium|||cyclic diguanylate diammonium;3'-Guanylic acid, guanylyl-(3'→5')-, cyclic nucleotide, diammonium salt (9CI)
CBNumber:
CB111010662
Summenformel:
C20H27N11O14P2
Molgewicht:
707.45
MOL-Datei:
609343-82-0.mol

3'-Guanylic acid, guanylyl-(3'→5')-, cyclic nucleotide, diammonium salt (9CI) Eigenschaften

storage temp. 
Store at -20°C
Aggregatzustand
Solid
Farbe
White to off-white

Sicherheit

3'-Guanylic acid, guanylyl-(3'→5')-, cyclic nucleotide, diammonium salt (9CI) Chemische Eigenschaften,Einsatz,Produktion Methoden

3'-Guanylic acid, guanylyl-(3'→5')-, cyclic nucleotide, diammonium salt (9CI) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

3'-Guanylic acid, guanylyl-(3'→5')-, cyclic nucleotide, diammonium salt (9CI) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Aladdin Scientific
tp@aladdinsci.com United States 52924 58
TargetMol Chemicals Inc. 		+8613564774135
 zijue.cai@tsbiochem.com United States 19881 58
Beijing Solarbio Science & Tecnology Co., Ltd. 010-50973130 4009686088
 3193328036@qq.com China 29764 68
TargetMol Chemicals Inc. 15002134094
 marketing@targetmol.cn China 19699 58
  • 3'-Guanylic acid, guanylyl-(3'→5')-, cyclic nucleotide, diammonium salt (9CI)
  • Cyclic-di-GMP diammonium
  • 5GP-5GP diammonium|||c-di-GMP diammonium
  • 5GP-5GP diammonium|||c-di-GMP diammonium|||cyclic diguanylate diammonium
  • cyclic diguanylate diammonium
  • 609343-82-0
  • C20H27N11O14P2
Copyright 2019 ? ChemicalBook. All rights reserved